# E-DRUG: Problem suppliers (cont'd) **URL:** \ **Category:** e-drug\ **Created:** [July 1, 1999, 4:18pm UTC](https://talk.edrugplus.org/t/e-drug-problem-suppliers-contd/5455 "1999-07-01T16:18:57Z")\ **Posts on this page:** 2\ **Page:** 1
**Author:** ![hamis1](https://avatars.discourse-cdn.com/v4/letter/h/e99b99/32.png) [@hamis1](https://talk.edrugplus.org/u/hamis1)\ **Post date:** [July 1, 1999, 4:18pm UTC](https://talk.edrugplus.org/t/e-drug-problem-suppliers-contd/5455/1 "1999-07-01T16:18:57Z")
------------------------------------------------------ E-DRUG Problem drugs I think Dzul's suggestion of "event reporting" is a good one. There needs to be some sort of international sharing of information. Information reported to National Authorities unfortunately remains within the bounds of the particular authority and is not shared more widely - be it in the form of lists, events ... In some developing countries a Regulatory Authority may not be in existence. If there is no sharing of information of this nature then more than a few people's lives may be at risk. This issue should not be about protecting national pride or particular manufacturers. It should be about the sharing of information for the common good of patients. A reputable company with GMP in place may have one or two recalls. If information is shared properly, one should be able to see the reason for the recall or particular batch related problem from the report. Companies who for one or other reason produce substandard products on a regular basis deserve to have their reputation sullied. If we must protect the interests of substandard manufacturers by not mentioning their names, then information could be shared on a per product basis. There should preferably be a standard format for sharing information too. Leesette Turner Leesette Turner snail: PO Box 21638, Kloof Street, 8008, SA tel: (+27)083-261-3299 tel/fax: (+27-21-)4651158 -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'. ---
**Author:** ![Dzulkifli\_Abdul\_Raza](https://avatars.discourse-cdn.com/v4/letter/d/c0e974/32.png) [@Dzulkifli\_Abdul\_Raza](https://talk.edrugplus.org/u/Dzulkifli_Abdul_Raza)\ **Post date:** [July 4, 1999, 12:17pm UTC](https://talk.edrugplus.org/t/e-drug-problem-suppliers-contd/5455/2 "1999-07-04T12:17:48Z")
----------------------------------------------- E-DRUG Criteria for Problem suppliers As a follow up to Leesette's suggestion can we look at the 5 categories below in trying to evolve a MINIMUM standard reporting format about "problem drug events" as a form of info sharing. Name of Drugs (and accompanying detailed documentation, eg. product name, batch number, manufacturer's name/number, supplier/agent/distributor information, etc) Description of Event (i.e, the problem encountered, with indication of the time/date of the event as a matter of reference) Any confirmation of the problem (especially with respect to Lab. QC) Any action taken to rectify ther problem (and outcome if possible) Any advisory note (to others) Regards, Dzul National Poison Centre Malaysia Dzulkifli Abdul Razak \ -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.